Abstract
Influenza remains a major contributor to the global burden of acute respiratory disease. The direct and indirect costs associated with influenza are substantial, particularly in the very young. Influenza vaccination has been recommended since 2008 for all children aged six to fifty nine months in Western Australia.
This PhD demonstrates the effectiveness of inactivated influenza vaccine in young children, preventing both emergency presentation and hospitalisation (2008-2014). In addition, it examines influenza vaccine coverage before and after adverse events observed with influenza vaccine in 2010 and identifies patient and parental factors which influence coverage and acceptance of influenza vaccination.
This PhD demonstrates the effectiveness of inactivated influenza vaccine in young children, preventing both emergency presentation and hospitalisation (2008-2014). In addition, it examines influenza vaccine coverage before and after adverse events observed with influenza vaccine in 2010 and identifies patient and parental factors which influence coverage and acceptance of influenza vaccination.
Original language | English |
---|---|
Qualification | Doctor of Philosophy |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 20 Jun 2016 |
Publication status | Unpublished - 2016 |